Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats.

Tytuł:
Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats.
Autorzy:
Xu G; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. xg_.; Shanghai University of Traditional Chinese Medicine, Shanghai, 201210, China. xg_.
Zhao X; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.; Shanghai University of Traditional Chinese Medicine, Shanghai, 201210, China.
Li Z; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Hu J; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Li X; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Li J; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Chen Y; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. .
Źródło:
Journal of ovarian research [J Ovarian Res] 2023 Jan 17; Vol. 16 (1), pp. 15. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: [London] : BioMed Central, c2008-
MeSH Terms:
Electroacupuncture*
Hyperandrogenism*
Polycystic Ovary Syndrome*/metabolism
Polycystic Ovary Syndrome*/therapy
Animals ; Female ; Humans ; Rats ; Androgens/metabolism ; Dynorphins/metabolism ; Estrogen Receptor alpha/metabolism ; Gonadal Steroid Hormones ; Gonadotropin-Releasing Hormone ; Kisspeptins/metabolism ; Luteinizing Hormone ; Neurokinin B/metabolism ; Neurons ; Rats, Sprague-Dawley ; Receptors, Androgen/metabolism ; Receptors, Kisspeptin-1/metabolism ; RNA, Messenger/metabolism
References:
Gynecol Endocrinol. 2018 Feb;34(2):157-160. (PMID: 28933574)
Hum Reprod. 2012 Oct;27(10):3067-73. (PMID: 22777527)
Endocrinology. 2010 Jan;151(1):301-11. (PMID: 19880810)
J Clin Endocrinol Metab. 2000 Jul;85(7):2434-8. (PMID: 10902790)
Am J Physiol Endocrinol Metab. 2013 May 1;304(9):E934-43. (PMID: 23482444)
Neuroendocrinology. 2013;97(2):193-202. (PMID: 22377698)
Endocrinology. 2018 Apr 1;159(4):1734-1747. (PMID: 29471436)
J Clin Endocrinol Metab. 2005 May;90(5):2810-5. (PMID: 15728200)
Endocrinol Metab Clin North Am. 1988 Dec;17(4):705-32. (PMID: 2973982)
Reprod Biomed Online. 2009;19 Suppl 4:4331. (PMID: 20034417)
Endocrinology. 2017 Feb 1;158(2):367-377. (PMID: 27983870)
Zhen Ci Yan Jiu. 2019 Oct 25;44(10):740-6. (PMID: 31657164)
Gynecol Endocrinol. 2013 Apr;29(4):391-5. (PMID: 23327685)
PLoS One. 2013 Nov 18;8(11):e79382. (PMID: 24260211)
Mol Med. 2020 Jul 22;26(1):73. (PMID: 32698821)
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4045-4047. (PMID: 28377515)
Arch Med Res. 2004 Mar-Apr;35(2):103-8. (PMID: 15010188)
Endocrinology. 2002 Nov;143(11):4366-74. (PMID: 12399433)
Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22693-8. (PMID: 21149719)
J Neurosci. 2009 Sep 23;29(38):11859-66. (PMID: 19776272)
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):. (PMID: 33500349)
Reprod Sci. 2022 Jul 7;:. (PMID: 35799018)
Trials. 2019 Sep 11;20(1):564. (PMID: 31511054)
Med Acupunct. 2019 Dec 1;31(6):379-383. (PMID: 31871526)
J Clin Endocrinol Metab. 1998 Feb;83(2):582-90. (PMID: 9467578)
Neuroendocrinology. 2018;106(4):389-400. (PMID: 29635226)
Complement Ther Med. 2019 Jun;44:182-188. (PMID: 31126554)
Endocrinology. 2005 Jul;146(7):2976-84. (PMID: 15831567)
Evid Based Complement Alternat Med. 2020 Jul 14;2020:3608062. (PMID: 32733580)
Acupunct Med. 2021 Oct;39(5):491-500. (PMID: 33406849)
Endocrinology. 2015 Feb;156(2):576-88. (PMID: 25490143)
J Clin Endocrinol Metab. 1998 Sep;83(9):3078-82. (PMID: 9745406)
Endocrinology. 2008 Jul;149(7):3559-68. (PMID: 18388196)
Endocrinology. 2020 Apr 1;161(4):. (PMID: 32031594)
J Neuroendocrinol. 2009 Mar;21(4):305-11. (PMID: 19207812)
Biol Reprod. 2004 Feb;70(2):329-33. (PMID: 14561641)
Endocrine. 2018 Jul;61(1):149-157. (PMID: 29728876)
Reprod Med Biol. 2018 Dec 28;18(2):151-160. (PMID: 30996678)
J Ovarian Res. 2020 Sep 13;13(1):106. (PMID: 32921318)
Biomed Pharmacother. 2019 May;113:108687. (PMID: 30851546)
J Clin Endocrinol Metab. 2000 Nov;85(11):4047-52. (PMID: 11095431)
Arch Gynecol Obstet. 2017 Nov;296(5):957-963. (PMID: 28875319)
Neurosci Lett. 2006 Jul 3;401(3):225-30. (PMID: 16621281)
Neuroendocrinology. 2020;110(7-8):582-594. (PMID: 31484184)
Hum Reprod. 2013 Sep;28(9):2562-9. (PMID: 23814096)
Biol Res. 2020 Oct 27;53(1):50. (PMID: 33109277)
Exp Physiol. 2012 May;97(5):651-62. (PMID: 22337865)
Biol Reprod. 2015 Sep;93(3):69. (PMID: 26203175)
J Postgrad Med. 2019 Jan-Mar;65(1):18-23. (PMID: 30004037)
Endocrinology. 2021 Nov 1;162(11):. (PMID: 34346492)
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3334-E3343. (PMID: 28320971)
J Clin Endocrinol Metab. 1988 Jan;66(1):165-72. (PMID: 2961784)
BMJ Open. 2019 Jan 4;9(1):e024733. (PMID: 30612112)
J Clin Endocrinol Metab. 1986 Jul;63(1):215-21. (PMID: 3086357)
Gynecol Endocrinol. 2016 Sep;32(9):718-722. (PMID: 27003383)
Arch Gynecol Obstet. 2019 Nov;300(5):1423-1434. (PMID: 31584133)
Front Endocrinol (Lausanne). 2021 Sep 09;12:724632. (PMID: 34566891)
Cureus. 2021 Aug 31;13(8):e17600. (PMID: 34646652)
Grant Information:
2020013 This study was supported by the Shanghai Leading Talents Training Program .
Contributed Indexing:
Keywords: Androgen receptor; Electroacupuncture; Gonadotropin releases hormone; Kisspeptin; Polycystic ovary syndrome
Substance Nomenclature:
0 (Androgens)
74913-18-1 (Dynorphins)
0 (Estrogen Receptor alpha)
0 (Gonadal Steroid Hormones)
33515-09-2 (Gonadotropin-Releasing Hormone)
0 (Kisspeptins)
9002-67-9 (Luteinizing Hormone)
86933-75-7 (Neurokinin B)
0 (Receptors, Androgen)
0 (Receptors, Kisspeptin-1)
0 (RNA, Messenger)
Entry Date(s):
Date Created: 20230117 Date Completed: 20230120 Latest Revision: 20230122
Update Code:
20230123
PubMed Central ID:
PMC9844031
DOI:
10.1186/s13048-022-01078-x
PMID:
36650561
Czasopismo naukowe
Background: Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, anovulation, and polycystic ovaries. Electroacupuncture (EA) can effectively improve hyperandrogenism and increase ovulation frequency in patients with PCOS. Pieces of suggest that androgen activity in the brain is associated with impaired steroid negative feedback in such patients. Studies have shown that EA regulated androgen receptor (AR) expression and local factor levels (such as anti-Müllerian hormone and inhibin B) in the ovary of PCOS rats. However, few studies have explored the effect of EA on androgen activity in the brain.
Objective: This study investigated the effect of EA on the kisspeptin-gonadotropin-releasing hormone (GnRH)/luteinizing hormone (LH) neural circuit and sex hormone receptor expression in the hypothalamus of PCOS rats.
Methods: PCOS signs were induced by letrozole administration, and the induced rats were treated with low-frequency EA at Guan Yuan acupoint (CV4). The effect of EA on PCOS-like signs was evaluated by observing changes in the body weight, ovarian quality, ovarian morphology, and serum sex hormone levels in rats. To explore the mechanism of the effect of EA on PCOS-like signs, the neuropeptide content of the kisspeptin-GnRH/LH neural circuit was assessed using enzyme-linked immunosorbent assay(ELISA); AR and estrogen receptor α (ERα) coexpression on kisspeptin/neurokinin B/dynorphin (KNDy) neurons was determined via triple-label immunofluorescence; and protein and mRNA expression of Kiss1, Ar, Esr1, and kisspeptin receptor (Kiss1r) was evaluated via western blotting and Reverse Transcription-Polymerase Chain Reaction (RT-PCR).
Results: The results revealed that the estrous cycle of rats in the EA treatment group recovered, and their body and ovary weight reduced; ovarian morphology improved; serum testosterone and LH levels significantly decreased; and kisspeptin, GnRH, and dynorphin levels in hypothalamic arcuate nucleus significantly decreased. Compared with controls, the number of AR/Kiss1-positive cells increased, number of ERα/Kiss1-positive cells decreased, and protein and mRNA expression of Kiss1, Ar, and Kiss1r significantly increased in PCOS rats. However, EA treatment reversed these changes and reduced the expression of Kiss1, Ar, and Kiss1r significantly.
Conclusion: Improvement in the reproductive hallmarks of PCOS rats via EA may be achieved by regulating the kisspeptin-GnRH/LH circuit via androgen activity attenuation. Thus, the results provide an experimental basis for acupuncture as an adjuvant medical therapy on PCOS.
(© 2023. The Author(s).)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies